Fermenta Biotech Stock Screener | Share Price & Fundamental Analysis
FERMENTA
Pharmaceuticals
Share Price BSE
₹325.80
▼
-10.25 (-3.05%)
As of April 13, 2026, the Fermenta Biotech share price (BSE: FERMENTA) is ₹325.80, down 3.05% from the previous close, with shares trading between ₹323.40 and ₹336.00, and a 52-week range of ₹256.25–₹393.90.
Browse FERMENTA cash flow statement to support your investment research.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Fermenta Biotech Market Cap
₹989.04 Cr.
FERMENTA P/E Ratio (TTM)
11.60
Fermenta Biotech P/B Ratio
2.52
EPS (TTM)
₹26.35
Dividend Yield
0.74%
Debt to Equity
0.39
FERMENTA 52 Week High
₹393.90
Fermenta Biotech 52 Week Low
₹256.25
Operating Margin
26.00%
Profit Margin
22.92%
FERMENTA Revenue (TTM)
₹144.00
EBITDA
₹41.00
Net Income
₹33.00
Total Assets
₹615.00
Total Equity
₹359.00
Fermenta Biotech Share Price History - Stock Screener Chart
Screen FERMENTA historical share price movements with interactive charts. Analyze price trends and patterns.
Fermenta Biotech Company Profile - Fundamental Screener
Screen Fermenta Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for FERMENTA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE225B01021
Fermenta Biotech Balance Sheet Screener
Screen FERMENTA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 615 | 548 | 637 | 707 | 687 | 614 | 551 | 387 | 308 | 288 |
| Current Assets | 335 | 242 | 253 | 314 | 310 | 284 | 296 | 182 | 104 | 95 |
| Fixed Assets | 227 | 269 | 267 | 299 | 263 | 200 | 178 | 177 | 172 | 168 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 44 | 89 | 115 | 128 | 117 | 110 | 145 | 146 | 49 | 24 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 359 | 285 | 313 | 372 | 360 | 309 | 251 | 137 | 173 | 156 |
| Share Capital | 15 | 14 | 14 | 14 | 14 | 14 | 5 | 2 | 2 | 2 |
| Reserves & Surplus | 348 | 274 | 301 | 358 | 346 | 295 | 246 | 124 | 142 | 128 |
Fermenta Biotech Income Statement Screener - Profit & Revenue Analysis
Screen Fermenta Biotech income statement and profit fundamentals.
Analyze FERMENTA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Fermenta Biotech share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 144 | 145 | 136 | 141 | 103 | 81 | 98 | 159 | 106 | 85 | 59 | 102 | 99 | 96 | 101 |
| Expenses | 103 | 108 | 104 | 115 | 92 | 77 | 76 | 103 | 95 | 72 | 78 | 74 | 78 | 87 | 95 |
| EBITDA | 41 | 37 | 32 | 26 | 11 | 4 | 22 | 56 | 11 | 13 | -19 | 28 | 21 | 9 | 6 |
| Operating Profit % | 26.00% | 21.00% | 20.00% | 17.00% | 6.00% | 1.00% | 20.00% | 34.00% | 10.00% | 13.00% | -38.00% | 25.00% | 18.00% | 5.00% | 3.00% |
| Depreciation | 6 | 6 | 5 | 5 | 7 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 | 9 |
| Interest | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 | 6 | 5 | 4 | 5 | 4 | 5 | 5 |
| Profit Before Tax | 32 | 28 | 24 | 18 | 1 | -6 | 12 | 45 | -1 | 2 | -29 | 16 | 10 | -2 | -8 |
| Tax | -1 | 7 | 6 | 6 | 8 | 0 | 1 | 8 | 4 | 0 | 0 | 6 | 2 | 0 | 1 |
| Net Profit | 33 | 22 | 18 | 12 | -7 | -6 | 11 | 38 | -5 | 2 | -29 | 10 | 8 | -3 | -9 |
| EPS | 11.79 | 7.49 | 6.20 | 4.36 | -2.41 | -2.01 | 3.94 | 12.71 | -1.42 | 0.64 | -7.32 | 3.41 | 2.66 | -0.90 | -2.80 |
Fermenta Biotech Cash Flow Screener - Liquidity Fundamentals
Screen FERMENTA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 41 | 105 | 116 | 43 | 63 | 35 | 90 | 59 | 2 | 4 |
| Investing Activities | 0 | -16 | -55 | -26 | -41 | -44 | -97 | -101 | 7 | -13 |
| Financing Activities | -51 | -91 | -41 | -22 | -1 | -48 | 12 | 89 | -12 | 10 |
| Net Cash Flow | -10 | -1 | 19 | -4 | 21 | -57 | 6 | 47 | -4 | 2 |
Fermenta Biotech Shareholding Pattern Screener
See Fermenta Biotech shareholding pattern with promoter, FII, and DII holdings.
Check Fermenta Biotech promoter holding and ownership changes for FERMENTA on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 64.09% | 64.09% | 64.09% | 64.09% | 62.06% | 62.06% | 62.06% | 62.06% |
| FII Holding | 0.02% | 0.02% | 0.02% | 0.02% | 0.00% | 0.00% | 0.05% | 0.02% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 30.38% | 29.60% | 29.76% | 29.48% | 32.47% | 32.51% | 31.29% | 32.31% |
| Other Holding | 5.51% | 6.29% | 6.12% | 6.41% | 5.47% | 5.43% | 6.59% | 5.60% |
| Shareholder Count | 12,930 | 12,845 | 13,760 | 14,139 | 15,178 | 14,589 | 13,221 | 12,922 |
Fermenta Biotech Share Dividend Screener - Share Yield Analysis
Check Fermenta Biotech dividend history with payout and yield data.
View Fermenta Biotech dividend details including ex-dates and amounts for FERMENTA stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹2.50 | 0.78% |
| 2024-March | ₹1.25 | 0.46% |
| 2023-March | ₹1.25 | 0.83% |
| 2022-March | ₹1.25 | 1.12% |
| 2021-March | ₹2.50 | 1.22% |
| 2020-March | ₹5.00 | 2.00% |
| 2019-March | ₹1.25 | 0.59% |
| 2018-March | ₹2.50 | 0.91% |
| 2017-March | ₹2.50 | 1.05% |
Fermenta Biotech Stock Index Membership
See which indices include Fermenta Biotech stock.
Check FERMENTA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Fermenta Biotech Market Events Screener - Corporate Actions
Get Fermenta Biotech corporate actions including splits, bonuses, and buybacks.
Check Fermenta Biotech stock events that may affect FERMENTA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Extraordinary General Meeting | NA | -5.20% | ||
| Dividend | ₹ 1.25 /share | 19.56% | ||
| 2026-02-09 | 2026-02-09 | Quarterly Result Announcement | NA | -0.20% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 3.74% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | -2.81% |
| 2025-08-12 | 2025-08-12 | Annual General Meeting | NA | 17.70% |
| 2025-08-06 | 2025-08-06 | Dividend | ₹ 2.50 /share | 22.43% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -1.97% |
| 2025-02-11 | 2025-02-11 | Quarterly Result Announcement | NA | 11.80% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -5.12% |
| 2024-08-12 | 2024-08-12 | Annual General Meeting | NA | 52.13% |
| 2024-08-06 | 2024-08-06 | Dividend | ₹ 1.25 /share | 46.02% |
| 2022-08-04 | 2022-08-05 | Dividend | ₹ 1.25 /share | -3.77% |
| 2021-08-25 | 2021-08-27 | Dividend | ₹ 2.50 /share | -12.85% |
| 2020-02-13 | 2020-02-14 | Bonus | 2:1 | 15.38% |
Fermenta Biotech Competitors Screener - Peer Comparison
Screen FERMENTA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 397,066 | 37.62 | 54,729 | 9.71% | 10,980 | 34.03 |
| Divis Laboratories | 162,374 | 63.80 | 9,712 | 18.67% | 2,191 | 53.67 |
| Torrent Pharmaceuticals | 140,631 | 60.97 | 11,539 | 6.99% | 1,911 | 47.83 |
| Lupin | 106,665 | 22.48 | 22,910 | 13.74% | 3,306 | 57.51 |
| Dr Reddys Laboratories | 102,845 | 18.32 | 33,741 | 16.73% | 5,725 | 45.58 |
| Cipla | 99,317 | 21.81 | 28,410 | 7.12% | 5,291 | 40.75 |
| Zydus Life Science | 92,111 | 18.06 | 23,511 | 18.55% | 4,615 | 57.32 |
| Mankind Pharma | 85,822 | 47.03 | 12,744 | 20.90% | 2,007 | 51.63 |
| Aurobindo Pharma | 78,373 | 22.33 | 32,346 | 9.43% | 3,484 | 65.82 |
| Alkem Laboratories | 65,043 | 26.50 | 13,458 | 3.70% | 2,216 | 53.68 |
Fermenta Biotech Company Announcements - News Screener
Screen FERMENTA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-31 | Closure of Trading Window | - |
| 2026-02-28 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-11 | Intimation Of Investor Presentation - Q3/9Mofy26 | - |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-02-09 | Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025 | - |
| 2026-02-09 | Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025. | - |
| 2026-02-02 | Board Meeting Intimation for Unaudited Financial Results For Quarter And Nine Months Ended December 31 2025. | - |
| 2026-01-21 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-31 | Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_Order | - |
| 2025-12-29 | Closure of Trading Window | - |
| 2025-12-24 | Press Release | - |
| 2025-12-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2025-12-10 | Announcement under Regulation 30 (LODR)-Raising of Funds | - |
| 2025-12-10 | Board Meeting Outcome for Approval For The Proposal For Raising Of Funds. | - |
| 2025-12-10 | Update On Capacity Addition At Dahej Facility. | - |
| 2025-12-07 | Board Meeting Intimation for To Consider The Proposal For Raising Of Funds. | - |
| 2025-12-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2025-11-12 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |